{
    "organizations": [],
    "uuid": "77497fdb561e81c341b652267ac095994a62a429",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-eyegate-pharma-submits-investigati/brief-eyegate-pharma-submits-investigational-device-exemption-amendment-for-second-pilot-study-of-ocular-bandage-gel-idUSFWN1QQ0UX",
    "ord_in_thread": 0,
    "title": "Eyegate Pharma Submits Investigational Device Exemption Amendment For Second Pilot Study Of Ocular Bandage Gel",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 8 (Reuters) - Eyegate Pharmaceuticals Inc:\n* EYEGATE PHARMA SUBMITS INVESTIGATIONAL DEVICE EXEMPTION AMENDMENT FOR SECOND PILOT STUDY OF OCULAR BANDAGE GEL\n* EYEGATE PHARMACEUTICALS - SUBMITTED AMENDED IDE APPLICATION TO U.S. FDA FOR A PILOT STUDY OF EYEGATE OCULAR BANDAGE GEL\n* EYEGATE PHARMACEUTICALS INC - AMENDMENT SUMMARIZES CO’S RESPONSES TO FDA’S QUESTIONS AND COMMENTS IN RESPONSE TO ORIGINAL IDE SUBMISSION\n* EYEGATE PHARMACEUTICALS INC - AMENDMENT INCLUDES VALIDATION DATA ON MANUFACTURING PROCESSES AND BIOBURDEN TESTS RELATED TO PRODUCTION OF EYEGATE OBG\n* EYEGATE PHARMACEUTICALS INC - CONTINUE TO MOVE FORWARD TOWARD PLANNED 510(K) DE NOVO FILING IN 2019 FOR EYEGATE OBG Source text for Eikon:\n ",
    "published": "2018-03-08T21:41:00.000+02:00",
    "crawled": "2018-03-08T16:01:22.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "eyegate",
        "pharmaceutical",
        "inc",
        "eyegate",
        "pharma",
        "submits",
        "investigational",
        "device",
        "exemption",
        "amendment",
        "second",
        "pilot",
        "study",
        "ocular",
        "bandage",
        "gel",
        "eyegate",
        "pharmaceutical",
        "submitted",
        "amended",
        "ide",
        "application",
        "fda",
        "pilot",
        "study",
        "eyegate",
        "ocular",
        "bandage",
        "gel",
        "eyegate",
        "pharmaceutical",
        "inc",
        "amendment",
        "summarizes",
        "co",
        "response",
        "fda",
        "question",
        "comment",
        "response",
        "original",
        "ide",
        "submission",
        "eyegate",
        "pharmaceutical",
        "inc",
        "amendment",
        "includes",
        "validation",
        "data",
        "manufacturing",
        "process",
        "bioburden",
        "test",
        "related",
        "production",
        "eyegate",
        "obg",
        "eyegate",
        "pharmaceutical",
        "inc",
        "continue",
        "move",
        "forward",
        "toward",
        "planned",
        "k",
        "de",
        "novo",
        "filing",
        "eyegate",
        "obg",
        "source",
        "text",
        "eikon"
    ]
}